Compounds > nitroaspirin
Page last updated: 2024-09-03

nitroaspirin and Cancer of Ovary

nitroaspirin has been researched along with Cancer of Ovary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bratasz, A; Ignarro, LJ; Kuppusamy, P; Parinandi, NL; Sridhar, R; Weir, NM; Zweier, JL1
Bratasz, A; Ignarro, LJ; Kuppusamy, P; Selvendiran, K; Tong, L1
Bobko, A; Bratasz, A; Ignarro, LJ; Khramtsov, VV; Kuppusamy, P; Selvendiran, K; Wasowicz, T1

Other Studies

3 other study(ies) available for nitroaspirin and Cancer of Ovary

ArticleYear
Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Mar-07, Volume: 103, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Electron Spin Resonance Spectroscopy; Female; Glutathione; Humans; Neoplasm Recurrence, Local; Nitric Oxide; Nitric Oxide Donors; Ovarian Neoplasms; Tumor Stem Cell Assay

2006
NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts.
    Cell cycle (Georgetown, Tex.), 2008, Jan-01, Volume: 7, Issue:1

    Topics: Animals; Aspirin; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; ErbB Receptors; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT3 Transcription Factor; Transplantation, Heterologous

2008
NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.
    Journal of translational medicine, 2008, Feb-26, Volume: 6

    Topics: Animals; Antineoplastic Agents; Aspirin; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Mice; Mice, Nude; Molecular Structure; Nitro Compounds; Ovarian Neoplasms; Sensitivity and Specificity; Statistics as Topic; Sulfhydryl Compounds; Xenograft Model Antitumor Assays

2008